Part #1 & 2: COO Damon Michaels On Mydecine’s Collaboration With Johns Hopkins University Aug 27, 2021
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004 Jun 24, 2021